NL191707C - 1-Allyl- of 1-alkyl-2-(4-amino-2-methoxybenzamidomethyl)pyrrolidine, waarvan de benzeenkern op de 5-plaats nog een substituent draagt, alsmede geneesmiddelen, die deze verbindingen bevatten. - Google Patents

1-Allyl- of 1-alkyl-2-(4-amino-2-methoxybenzamidomethyl)pyrrolidine, waarvan de benzeenkern op de 5-plaats nog een substituent draagt, alsmede geneesmiddelen, die deze verbindingen bevatten.

Info

Publication number
NL191707C
NL191707C NL7900457A NL7900457A NL191707C NL 191707 C NL191707 C NL 191707C NL 7900457 A NL7900457 A NL 7900457A NL 7900457 A NL7900457 A NL 7900457A NL 191707 C NL191707 C NL 191707C
Authority
NL
Netherlands
Prior art keywords
methoxybenzamidomethyl
pyrrolidine
allyl
substituent
amino
Prior art date
Application number
NL7900457A
Other languages
English (en)
Dutch (nl)
Other versions
NL7900457A (nl
NL191707B (nl
Original Assignee
Soc Et Scient Et Ind De L Ile
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc Et Scient Et Ind De L Ile filed Critical Soc Et Scient Et Ind De L Ile
Publication of NL7900457A publication Critical patent/NL7900457A/xx
Publication of NL191707B publication Critical patent/NL191707B/xx
Application granted granted Critical
Publication of NL191707C publication Critical patent/NL191707C/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • C07D207/09—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
NL7900457A 1978-01-20 1979-01-19 1-Allyl- of 1-alkyl-2-(4-amino-2-methoxybenzamidomethyl)pyrrolidine, waarvan de benzeenkern op de 5-plaats nog een substituent draagt, alsmede geneesmiddelen, die deze verbindingen bevatten. NL191707C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7801632A FR2415099A1 (fr) 1978-01-20 1978-01-20 Nouveaux derives de 4-amino-5-alkylsulfonyl ortho-anisamides, leurs procedes de preparation et leur application comme psychotropes

Publications (3)

Publication Number Publication Date
NL7900457A NL7900457A (nl) 1979-07-24
NL191707B NL191707B (nl) 1995-12-01
NL191707C true NL191707C (nl) 1996-04-02

Family

ID=9203689

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7900457A NL191707C (nl) 1978-01-20 1979-01-19 1-Allyl- of 1-alkyl-2-(4-amino-2-methoxybenzamidomethyl)pyrrolidine, waarvan de benzeenkern op de 5-plaats nog een substituent draagt, alsmede geneesmiddelen, die deze verbindingen bevatten.

Country Status (42)

Country Link
US (2) US4294828A (me)
JP (1) JPS6049192B2 (me)
AR (2) AR221354A1 (me)
AT (1) AT377977B (me)
AU (1) AU528561B2 (me)
BE (1) BE872585A (me)
BG (2) BG31496A3 (me)
CA (1) CA1101430A (me)
CH (1) CH637927A5 (me)
CS (1) CS226181B2 (me)
CY (1) CY1201A (me)
DD (1) DD141520A5 (me)
DE (1) DE2901181C2 (me)
DK (1) DK158346C (me)
EG (1) EG14045A (me)
ES (2) ES476755A1 (me)
FI (1) FI71126C (me)
FR (1) FR2415099A1 (me)
GB (2) GB2012765B (me)
GR (1) GR64431B (me)
HK (1) HK12184A (me)
HU (1) HU179793B (me)
IE (1) IE47798B1 (me)
IL (1) IL56411A (me)
IN (1) IN150226B (me)
IT (1) IT1164655B (me)
LU (1) LU80786A1 (me)
MC (1) MC1232A1 (me)
MX (2) MX5793E (me)
NL (1) NL191707C (me)
NO (1) NO151320C (me)
NZ (1) NZ189378A (me)
OA (1) OA06156A (me)
PH (2) PH15725A (me)
PL (2) PL116532B1 (me)
PT (1) PT69068A (me)
RO (2) RO76393A (me)
SE (2) SE448874B (me)
SU (1) SU820659A3 (me)
YU (2) YU42172B (me)
ZA (1) ZA79219B (me)
ZM (1) ZM579A1 (me)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2440946A2 (fr) * 1978-01-20 1980-06-06 Ile De France Nouveaux benzamides heterocycliques substitues, leurs procedes de preparation et leur application comme modificateurs du comportement
ZA818221B (en) * 1980-12-12 1982-10-27 Beecham Group Plc Pharmaceutical compounds
FR2550447B1 (fr) * 1983-08-10 1986-01-17 Ile De France Application du n-(ally-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulfamoyl benzamide comme antiagregant plaquettaire
FR2574795B1 (fr) * 1984-12-18 1987-11-20 Ile De France Nouveau procede industriel de synthese du n-((1'-allyl 2'-pyrrolidinyl) methyl) 2-methoxy 4,5-azimido benzamide
FR2584401B1 (fr) * 1985-07-04 1987-11-20 Ile De France Nouveau benzamide, son procede de preparation et son application dans le domaine therapeutique
US5260319A (en) * 1989-12-26 1993-11-09 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
US5227388A (en) * 1989-12-26 1993-07-13 Hoechst-Roussel Pharmaceuticals Incorporated Thienobenzoxepins and naphthothiophenes
FR2678266A1 (fr) * 1991-06-28 1992-12-31 Delagrange Laboratoires Nouveaux derives de 2-hydroxy 4-amino 5-ethylsulfonyl benzamide utiles comme anxiolytiques.
FR2699533A1 (fr) * 1992-12-21 1994-06-24 Mouhtaram Mohamed Dérivés de N-((1,4-dialkyl-6-arylpipérazine-2-yl)méthyl)benzamides. (Isomères cis et trans) Propriétés pharmacologiques et applications.
FR2753376B1 (fr) * 1996-09-18 1998-10-16 Synthelabo Compositions pharmaceutiques comprenant de l'amisulpride et leurs applications therapeutiques
FR2762213B1 (fr) * 1997-04-18 1999-05-14 Synthelabo Composition pharmaceutique a retention gastrique
US6169094B1 (en) * 1998-07-14 2001-01-02 Sanofi-Synthelabo Compositions of (S) (-)-amisulpride
US20030129186A1 (en) 2001-07-25 2003-07-10 Biomarin Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
BRPI0410271A (pt) * 2003-05-16 2006-05-16 Pfizer Prod Inc combinações terapêuticas de antipsicóticos atìpicos com moduladores de gaba, anticonvulsivantes ou benzodiazepinas
FR2857263B1 (fr) * 2003-07-09 2005-09-09 Sanofi Synthelabo Nouvelle composition pharmaceutique solide comprenant de l'amisulpride
BRPI0510942A (pt) * 2004-05-11 2007-07-17 Pfizer Prod Inc combinação de antipsicóticos atìpicos e antagonistas do receptor 5-ht1b
EP1879569A2 (en) * 2005-04-22 2008-01-23 Wyeth Therapeutic combinations for the treatment or prevention of psychotic disorders
SI1889198T1 (sl) 2005-04-28 2015-02-27 Proteus Digital Health, Inc. Farma-informacijski sistem
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
US7825156B2 (en) * 2007-02-02 2010-11-02 Copharms Method of treating bipolar depression with a benzamide derivative
JP2011526881A (ja) * 2008-06-25 2011-10-20 ファイザー・インク ジアリール化合物およびそれらの使用
US20100105755A1 (en) * 2008-09-12 2010-04-29 Auspex Pharmaceuticals, Inc. Substituted benzamide modulators of dopamine receptor
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
CN101898991B (zh) * 2009-05-31 2013-09-25 江苏天士力帝益药业有限公司 一种(s)(-)-氨磺必利d-(-)-酒石酸盐的合成方法
CN101628886B (zh) * 2009-08-25 2012-12-12 北京紫萌同达科技有限公司 一种2-甲氧基-4-氨基-5-乙砜基苯甲酸的合成方法
GB201004020D0 (en) 2010-03-11 2010-04-21 Acacia Pharma Ltd New therapeutic use
AU2016216578B2 (en) * 2010-03-11 2017-11-23 Acacia Pharma Limited The use of amisulpride as an anti-emetic
AU2014202535B2 (en) * 2010-03-11 2016-05-26 Acacia Pharma Limited The use of amisulpride as an anti-emetic
EP2582665A1 (en) 2010-06-17 2013-04-24 Lupin Limited An improved process for preparation of amisulpride
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN103304453A (zh) * 2013-06-18 2013-09-18 苏州诚和医药化学有限公司 两步法合成2-甲氧基-4-氨基-5-乙砜基苯甲酸
CN103319384A (zh) * 2013-06-18 2013-09-25 苏州诚和医药化学有限公司 制备2-甲氧基-4-氨基-5-乙砜基苯甲酸的方法
CN103450058B (zh) * 2013-09-18 2015-10-14 广安凯特医药化工有限公司 一种氨磺必利酸的制备方法
CN104725292B (zh) * 2015-03-23 2017-07-25 湖北荆江源制药股份有限公司 一种(s)(‑)‑氨磺必利的制备方法
GB201618425D0 (en) * 2016-11-01 2016-12-14 Acacia Pharma Ltd method
CN111233731B (zh) * 2016-11-28 2021-05-14 Lb制药公司 精神药剂及其用途
US11377421B2 (en) 2016-11-28 2022-07-05 Lb Pharmaceuticals Inc. Psychotropic agents and uses thereof
CN106995397B (zh) * 2016-12-12 2020-01-14 河北医科大学 R-氨磺必利药用盐、制备方法、晶型及其用途
GB201702250D0 (en) 2017-02-10 2017-03-29 Acacia Pharma Ltd Method
CN112236138B (zh) 2017-12-05 2024-05-31 赛诺维信制药公司 晶体形式及其制备方法
CA3084953A1 (en) 2017-12-05 2019-06-13 Sunovion Pharmaceuticals Inc. Nonracemic mixtures and uses thereof
CN110790693A (zh) * 2018-08-02 2020-02-14 北京万全德众医药生物技术有限公司 一种(s)(-)-氨磺必利的制备方法
SG11202113266YA (en) 2019-06-04 2021-12-30 Sunovion Pharmaceuticals Inc Modified release formulations and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3342826A (en) * 1964-01-13 1967-09-19 Ile De France Heterocyclic aminoalkyl benzamides
FR2313935A1 (fr) * 1975-06-10 1977-01-07 Ile De France Nouveaux benzamides substitues, leurs derives et leur procede de preparation
US3862139A (en) * 1972-06-23 1975-01-21 Delmar Chem Heterocyclic benzamide compounds
FR2244760B1 (me) * 1973-09-25 1980-06-27 Ile De France
FR2299862B1 (fr) * 1975-02-07 1978-07-21 Ile De France Nouveau
FR2294698A1 (fr) * 1974-12-18 1976-07-16 Synthelabo Nouveaux derives des methoxy-2 benzamides substitues, leurs sels, leur preparation et les medicaments qui en renferment
DE2556457C3 (de) * 1974-12-18 1981-02-12 Synthelabo S.A., Paris N-(Pyrrolidin-2-yl-methyl)-2-methoxybenzamide, deren Salze, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel

Also Published As

Publication number Publication date
NL7900457A (nl) 1979-07-24
PT69068A (fr) 1979-02-01
ES477782A1 (es) 1979-09-16
YU41278B (en) 1986-12-31
ZM579A1 (en) 1979-12-21
CA1101430A (en) 1981-05-19
AT377977B (de) 1985-05-28
FR2415099B1 (me) 1981-02-20
YU42172B (en) 1988-06-30
GB2083458B (en) 1983-03-09
FR2415099A1 (fr) 1979-08-17
PL118151B1 (en) 1981-09-30
NO790180L (no) 1979-07-23
NO151320B (no) 1984-12-10
OA06156A (fr) 1981-06-30
DK158346C (da) 1990-10-08
GB2012765A (en) 1979-08-01
DK20979A (da) 1979-07-21
CS226181B2 (en) 1984-03-19
PH15725A (en) 1983-03-18
US4294828A (en) 1981-10-13
NO151320C (no) 1985-04-17
ATA39879A (de) 1983-12-15
SE8603773D0 (sv) 1986-09-09
HK12184A (en) 1984-02-24
RO76393A (ro) 1981-03-30
MX5793E (es) 1984-07-19
IE790092L (en) 1979-07-20
SE460968B (sv) 1989-12-11
SE448874B (sv) 1987-03-23
ZA79219B (en) 1980-01-30
RO80311A (ro) 1982-12-06
YU5079A (en) 1983-06-30
SE7900380L (sv) 1979-07-21
NZ189378A (en) 1983-03-15
YU25483A (en) 1983-10-31
GB2083458A (en) 1982-03-24
GB2012765B (en) 1982-09-08
AR221354A1 (es) 1981-01-30
SU820659A3 (ru) 1981-04-07
IL56411A0 (en) 1979-03-12
FI790182A (fi) 1979-07-21
IN150226B (me) 1982-08-21
FI71126B (fi) 1986-08-14
EG14045A (en) 1983-09-30
IL56411A (en) 1982-09-30
FI71126C (fi) 1986-11-24
MC1232A1 (fr) 1979-10-26
DK158346B (da) 1990-05-07
CY1201A (en) 1983-12-31
BE872585A (fr) 1979-06-07
BG31497A3 (en) 1982-01-15
PH22287A (en) 1988-07-22
GR64431B (en) 1980-03-21
CH637927A5 (fr) 1983-08-31
JPS54145658A (en) 1979-11-14
JPS6049192B2 (ja) 1985-10-31
AU528561B2 (en) 1983-05-05
SE8603773L (sv) 1986-09-09
PL212899A1 (me) 1980-01-14
LU80786A1 (fr) 1979-09-07
DE2901181C2 (de) 1984-07-19
HU179793B (en) 1982-12-28
PL116532B1 (en) 1981-06-30
NL191707B (nl) 1995-12-01
BG31496A3 (en) 1982-01-15
DE2901181A1 (de) 1979-07-26
DD141520A5 (de) 1980-05-07
MX7623E (es) 1990-03-27
US4401822A (en) 1983-08-30
ES476755A1 (es) 1979-06-01
AU4337379A (en) 1979-07-26
IT1164655B (it) 1987-04-15
IE47798B1 (en) 1984-06-27
AR220574A1 (es) 1980-11-14
IT7947706A0 (it) 1979-01-18

Similar Documents

Publication Publication Date Title
NL191707C (nl) 1-Allyl- of 1-alkyl-2-(4-amino-2-methoxybenzamidomethyl)pyrrolidine, waarvan de benzeenkern op de 5-plaats nog een substituent draagt, alsmede geneesmiddelen, die deze verbindingen bevatten.
IT7825815A0 (it) Composti fotocromici.
NO810162L (no) Fluorerte vinyleterforbindelser.
NL7803198A (nl) Verbindingsorgaan.
NO783155L (no) Imidazolderivater.
NL7804094A (nl) Verbindingsorgaan.
NO783642L (no) Imidazolidenderivater.
NO790434L (no) Pyrrolidin-derivat.
NL191306C (nl) 4-Chinolonderivaat, alsmede geneesmiddel met dit derivaat.
IT8020635A0 (it) Impianto idraulico.
NL190781B (nl) N-acylfosfortriamiden, alsmede geneesmiddelen die N-acylfosfortriamiden bevatten.
IT7921159A0 (it) Composti eterociclici.
NL7900028A (nl) Pyrrolidonderivaten.
NL7810634A (nl) Tetrazool-derivaten.
NL7808356A (nl) Fungiciden.
IT7925538A0 (it) N-aril-n-acil-3-ammino-ossazolidin2-oni fungicidi.
IT8019330A0 (it) Barra alesatrice.
NL187674C (nl) Hydraulische wisselaandrijving.
NO802453L (no) Heterocykliske forbindelser.
IT7823151A0 (it) Nuove antracicline antitumorali sostituite.
IT7822928A0 (it) Nuovi derivati 1h-1,2,4-triazolici 3,5-disostituiti.
IT8023391A0 (it) Derivati pirrolidinici.
NL7808946A (nl) Beta-gesubstitueerde diketonen, alsmede preparaten die deze verbindingen bevatten.
NO780809L (no) Papirprodukt.
IT7924257A0 (it) Composti eterociclici.

Legal Events

Date Code Title Description
BV The patent application has lapsed
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 990119